![](/img/cover-not-exists.png)
Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals
Toru Hiraga, Hiroaki NakamuraVolume:
124
Year:
2009
Language:
english
Pages:
8
DOI:
10.1002/ijc.23903
File:
PDF, 1.14 MB
english, 2009